Healthy Clinical Trial
Official title:
The Effect of Heat on Blood and Oxygen Flow Readings Part 2
Verified date | February 2016 |
Source | VA Pittsburgh Healthcare System |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
This is the second part of a research study in order to determine if using a specialized
pulse oximetry probe with external heat pack will help obtain oxygen saturation (SaO2) and
heart rate (HR) during monitoring for patients with peripheral vascular disease (PVD),
vasoconstriction, and hypothermic extremities. The inability to obtain accurate SaO2 and
pulse readings can lead to misdiagnosis, incorrect treatment, or procedures to be canceled.
SaO2 and pulse readings are important to maintain patient stability during diagnostic
testing, surgical procedures and monitoring while in critical care areas. Changes in SaO2
and pulse are important to monitor in order to be able to compensate for any decrease in
patient oxygen saturations during hemodynamic monitoring.
The primary aim of this study is to determine if using a specialized pulse oximetry probe
with external heat pack will improve oxygenation readings in order to obtain SaO2 and pulse
readings in patients with PVD, vasoconstriction, and hypothermic extremities as compared to
readings obtained from an arterial blood gas.
The hypothesis is using a specialized pulse oximetry probe with external heat pack will help
obtain more accurate pulse oximetry readings consistent with values obtained with an
arterial blood gas.
Status | Completed |
Enrollment | 51 |
Est. completion date | December 2015 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Age > 18 years 2. Able to give informed consent 3. Patients must be able to read and understand English. 4. Patients scheduled to enter the VA Pittsburgh Healthcare System catheterization lab Arm 2 of the study: 1. The PI will determine if patients have poor circulation due to obstruction of the large arteries in their arms and legs (peripheral vascular disease (PVD), narrowing of their blood vessels (vasoconstriction), or extremities (arms, legs, etc) that are at least 3 degrees Fahrenheit below their normal body temperature. If patients do have any of the following they will be considered for arm 2. If they do not they will be considered for arm 1. Exclusion Criteria: In addition to the exclusions mentioned above, patients with the following conditions will be excluded from the trial: 1. Inability or unwillingness to sign informed consent with free will and sound mind, as determined by a score of <11 on the Evaluation to Sign Consent Form. |
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
United States | VA Pittsburgh Healthcare System | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
VA Pittsburgh Healthcare System | Medline Industries |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Temperature | measured at least every 5 minutes - day 1 | Yes | |
Primary | Pulse Oximetry | measured at least every 5 minutes - day 1 | No | |
Secondary | Arterial Blood Gas | measured once - day 1 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |